Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
gene therapy
6
×
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
vc
6
×
biotech
new york top stories
san diego blog main
san diego top stories
san francisco top stories
national
biogen
boulder/denver blog main
boulder/denver top stories
car-t
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
novartis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
spinal muscular atrophy
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
celgene
crispr
democrats
What
bio
gene
roundup
therapy
cutting
edge
healthcare
hot
ipo
launch
medicines
moves
new
remains
science
aiming
allogene
ambys
america
aren’t
becker
big
billions
biogen
biotech
cancer
car
continues
control
convoluted
crispr
crude
deadly
deal
debuted
democrats
despite
diseases
diversity
dollars
Language
Current search:
vc
×
" gene therapy "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”